Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

Point of Care Diagnostic Testing World Markets, 2018 - Research and Markets

DUBLIN, April 20, 2016 /PRNewswire/ --

Research and Marketshas announced the addition of the"Point of Care Diagnostic Testing World Markets"report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

This report describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections - both in the U.S. and worldwide - including Europe, Asia and Latin America.

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening.

It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each clinical market is provided with emphasis on newly introduced products. Moreover, parallel areas where rapid detection is important using hand-held devices such as rapid detection of food pathogens and infectious diseases (MRSA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed. Growth moderators and developing trends in point of care applications, as well as technology platform innovations and connectivity questions are examined in detail.

The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product lines, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.

Key Topics Covered:

1. Overview

2. Overview of Diagnostic Testing Point of Care Markets

3. Summary Analysis of the Global POCT Market: Value, Growth Rates and Market Share

4. Analysis of the U.S. POCT Market: Value, Growth Rates and Market Share

5. Analysis of the European POCT Market: Value, Growth Rates and Market Shares

6. Analysis of the POCT Markets for Japan, China and India: Value, Growth Rates and Market Share

7. Analysis of the Rest of World (ROW) POCT Market: Value, Growth Rates and Market Share

8. Review of the Market Segments, Reagents and Equipment

9. POCT: Growth Regulators

10. Business Trends in the POC Sector

11. Technology Platform Innovations in POCT

12. Data Management and Connectivity

13. Corporate Profiles

14. POCT Sector Trends and Forecasts

15. New Entrants to the Point of Care Market

Companies Mentioned - Partial List

- A. Menarini Diagnostics
- ACON Laboratories, Inc.
- Artron Laboratories, Inc.
- BioFire Diagnostics, Inc.
- BioMedomics
- BioScan Screening Systems, Inc.
- Biocartis SA
- Biomerica, Inc.
- Biosensia Ltd.
- Calypte Biomedical Corporation
- Chembio Diagnostic, Inc.
- Exalenz Bioscience
- GenBio
- LifeSign, LLC
- MBio Diagnostics, Inc.
- MedMira Laboratories
- Medica Corporation
- Medix Biochemica
- Menssana Research, Inc.
- Metaara Medical Technologies, Inc.
- Micronics
- New Horizons Diagnostics
- Nova Biomedical
- One Step Detect Associates, LLC
- Response Biomedical Corp.
- Roche Diagnostics
- Savyon Diagnostics
- Seegene
- Sekisui Diagnostics, LLC
- Senseonics
- Shanghai Ruicare Medical Co., Ltd.
- Shenzhen Fitconn Technology Co., Ltd.
- Telcare
- Trinity Biotech Plc
- bioMérieux


For more information visithttp://www.researchandmarkets.com/research/654wtk/point_of_care

Media Contact:

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.